We are live on ! Find out more

Catalyst Pharmaceutical

CPRX

90 hedge funds and large institutions have $134M invested in Catalyst Pharmaceutical in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 27 reducing their positions, and 12 closing their positions.

New

Increased

Maintained

Reduced

Closed

38% more call options, than puts

Call options by funds: $11K | Put options by funds: $8K

25% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 12

3% more funds holding

Funds holding: 87 → 90 (+3)

4% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 27

25% less capital invested

Capital invested by funds: $180M → $134M (-$45.6M)

Holders

Holders Change

Holders Change %

+3.45%

% of All Funds

2.51%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$11K

Puts

$8K

Net Calls

+$3K

Net Calls Change

-$510K

Top Buyers

1	JP Morgan Chase New York	+$3.02M
2	Northern Trust Chicago, Illinois	+$2.68M
3	Invesco Atlanta, Georgia	+$1.78M
4	Allianz Asset Management Munich, Germany	+$1.75M
5	State Street Boston, Massachusetts	+$1.59M

Top Sellers

1	Point72 Asset Management Stamford, Connecticut	-$5.43M
2	CCA Catalyst Capital Advisors Huntington, New York	-$4.34M
3	Franklin Resources San Mateo, California	-$1.66M
4	Morgan Stanley New York	-$1.39M
5	PVI Pura Vida Investments New York	-$1.27M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Bank of New York Mellon New York	$803K	-$185K	-42,947	-14%
27	TCIM 27 TIAA CREF Investment Management New York	$771K	+$452K	+104,663	+69%
28	KCM 28 Kennedy Capital Management St Louis, Missouri	$747K	+$1.08M	+249,071	New
29	29 Citadel Advisors Miami, Florida	$426K	+$270K	+62,462	+78%
30	30 AQR Capital Management Greenwich, Connecticut	$419K	-$195K	-45,220	-24%
31	31 D.E. Shaw & Co New York	$417K	-$290K	-67,258	-33%
32	ERSOT 32 Employees Retirement System of Texas Austin, Texas	$414K	–	–	–
33	33 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$411K	-$2.16K	-500	-0.4%
34	RFC 34 Russell Frank Company Seattle, Washington	$406K	-$287K	-66,473	-33%
35	WMSA 35 Weiss Multi-Strategy Advisers New York	$366K	-$34.5K	-8,000	-6%
36	TCM 36 Tanaka Capital Management New York	$335K	–	–	–
37	TA 37 Teachers Advisors New York	$332K	–	–	–
38	38 Charles Schwab San Francisco, California	$323K	–	–	–
39	PVI 39 Pura Vida Investments New York	$300K	-$1.27M	-294,871	-75%
40	40 RhumbLine Advisers Boston, Massachusetts	$206K	+$16.1K	+3,741	+6%
41	41 New York State Common Retirement Fund Albany, New York	$206K	+$110K	+25,507	+59%
42	BFM 42 Boothbay Fund Management New York	$191K	+$275K	+63,667	New
43	EI 43 EAM Investors Solana Beach, California	$183K	-$735K	-170,193	-74%
44	44 Bank of America Charlotte, North Carolina	$178K	-$157K	-36,334	-38%
45	SAM 45 Symphony Asset Management San Francisco, California	$165K	+$148K	+34,337	+165%
46	VKH 46 Virtu KCG Holdings New York	$152K	+$131K	+30,265	+147%
47	NFA 47 Nationwide Fund Advisors Columbus, Ohio	$145K	–	–	–
48	48 Morgan Stanley New York	$142K	-$1.39M	-323,205	-87%
49	MLICM 49 Metropolitan Life Insurance Company (MetLife) New York	$142K	-$40.7K	-9,426	-17%
50	HCM 50 Highbridge Capital Management New York	$137K	+$196K	+45,510	New

CPRX Hedge Fund Activity: Q3 2015 in Review

90 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Catalyst Pharmaceutical (CPRX) for Q3 2015, worth a combined $134M — down 25% from $180M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CPRX positions and 12 closed out — a net gain of 3 holders — while 28 added to existing stakes and 27 trimmed.

The largest buyer was JP Morgan Chase, opening a new position worth an estimated $3.02M. The largest seller was Point72 Asset Management, cutting an estimated $5.43M.

90 institutional investors held Catalyst Pharmaceutical (CPRX) as of Q3 2015, up from 87 in Q2 2015.
Funds reported $134M of Catalyst Pharmaceutical stock for Q3 2015, down 25% quarter-over-quarter.
15 funds opened new Catalyst Pharmaceutical positions in Q3 2015 and 12 closed out, a net change of +3 holders.
The largest Catalyst Pharmaceutical buyer in Q3 2015 was JP Morgan Chase, an estimated $3.02M added.
The largest Catalyst Pharmaceutical seller in Q3 2015 was Point72 Asset Management, an estimated $5.43M sold.

Based on aggregated 13F filings for Q3 2015.

Catalyst Pharmaceutical CPRX